entertainment -WSS

entertainment

author：Wikipedia 2025-09-30 12:08:22 - browse：899

Cell and gene therapy sign seen at a conference. -- biotech coverage from STAT — Jonathan Wosen for STAT

CARLSBAD, Calif. — Biotech CEOs leading cell and gene therapy companies spoke frankly at a conference here last week about the tough choices they’re making to preserve limited cash amid the industry’s ongoing slowdown.

The company leaders said that they’ve felt added pressure to use smaller teams to work quickly on fewer projects, and at times to partner with outside firms that have specific manufacturing and research expertise. Not all of these changes are bad, they added, noting that efficiency is a good trait for a biotech company in any market.

The candid conversation on Thursday was part of Meeting on the Mesa, an annual cell and gene therapy conference held in Carlsbad, in the north of San Diego County. And it provided a glimpse into discussions happening across the life science industry as biotech markets continue a sharp slump that dates back to late 2021.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Alabama frozen embryo ruling has major implications for IVF clinics

focus

WSS

CDC concerned about possible undetected monkeypox spread in U.K.

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Why palliative psychiatry is worth discussing

NIH study of ME/CFS points to clear biological hallmarks

Cloning humans is technically possible. It's curious no one has tried

CDC concerned about possible undetected monkeypox spread in U.K.

entertainment

entertainment

leisure time

Trump demands the U.S. pay no more for drugs than other countries … again

Disclosing genetic information: not as worrisome as once feared

United colonoscopy coverage change 'may cost lives,' doctors say

R1 RCM gets $5.8 billion buyout offer from private equity firm

The high cost of giving birth even with insurance

The Harvard botanist who searched for psychedelics in the Amazon

Trump demands the U.S. pay no more for drugs than other countries … again

Do masks work? RCTs can't tell us

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

R1 RCM gets $5.8 billion buyout offer from private equity firm

focus

Paxlovid study fails to answer questions over benefit for broader groups

What would happen to your eyes if you looked at the solar eclipse?

Ask STAT: What do you want to know about ChatGPT in medicine?

Why palliative psychiatry is worth discussing

New documents shed light on MD Anderson Cancer Institute feud

With FDA staff opposed to Sarepta therapy, top official intervened

focus

entertainment

knowledge

focus